Functional properties of maillard reaction products in food: Antimicrobial activity of aminoreductone against pathogenic bacteria by Trang, Vu Thu et al.
Food Sci. Technol. Res., 19 (5), 833–841, 2013
Functional Properties of Maillard Reaction Products in Food: Antimicrobial Activity 
of Aminoreductone against Pathogenic Bacteria
Vu Thu trang1*, Vu Hong son1, Lam Xuan thanh1, Samira sarter1,2,3, Tomoko shimamura4, Hiroyuki uKed4 and 
Hiroaki taKeuChi5*
1  School of Biotechnology and Food Technology, Hanoi University of Science and Technology, No. 1 Dai Co Viet, Hanoi, Vietnam
2  Cirad UMR Qualisud, 298 Kim Ma, 102 Bldg 2G, Hanoi, Vietnam
3  CIRAD, UMR Qualisud, F-34398 Montpellier, France
4  Faculty of Agriculture, Kochi University, B 200 Monobe, Nankoku, Kochi 783-8502, Japan
5  Department of Clinical Laboratory Medicine, Kochi University School of Medicine, Nankoku, Kochi 783-8505, Japan
Received March 27, 2013; Accepted May 24, 2013
Antimicrobial activities of aminoreductone (AR), a product formed in the initial stages of the Mail-
lard reaction, were investigated using eight clinical isolates of antibiotic-susceptible/resistant pathogenic 
bacteria: four Pseudomonas aeruginosa, one multi-drug-resistant Pseudomonas aeruginosa (MDRP), one 
Escherichia coli, one methicillin-susceptible Staphylococcus aureus, and one methicillin-resistant Staphy-
lococcus aureus (MRSA). AR showed advanced growth inhibition effects compared to antibiotics (ami-
kacin, ciprofloxacin, imipenem and levofloxacin) frequently used for the treatment of infectious diseases, 
and worked synergistically with these antibiotics. The minimum inhibitory concentrations (MIC) of AR 
ranged from 13 to 20 mM. The bactericidal activity of AR was dose and time dependent. The minimum 
bactericidal concentration (MBC) was lower for Gram-negative bacteria (32 to 40 mM). These findings 
suggest that AR, a naturally formed antimicrobial agent present in thermally processed foods, has prom-
ising potential for health promotion and for use in medical practices.
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Introduction
Since their discovery, antibiotics have provided the main 
basis for the treatment of infectious diseases caused by a 
variety of microorganisms in medical practices (Singh et al., 
2010). However, overuse and/or abuse of antibiotics have be-
come the main factor in the emergence and dissemination of 
multi-drug-resistant strains of bacteria (Singh et al., 2010). 
Multi-drug-resistant pathogens, such as methicillin-resistant 
Staphylococcus aureus (MRSA) and multi-drug-resistant 
Pseudomonas aeruginosa (MDRP), are widely distributed in 
hospitals and are increasingly being isolated from commu-
nity-acquired infections (Rao and Wong, 2003; Khan et al., 
2004). Currently, antibiotic resistance in pathogenic bacteria 
is a significant clinical problem and a serious public health 
concern (Manikandan et al., 2011). Thus, the identification of 
new antimicrobial agents is a top research and development 
priority among scientists and pharmaceutical companies 
(Alekshun and Levy, 2007).
The Maillard reaction, a heat-treatment-induced chemical 
reaction between amino and carbonyl groups, is important 
in food processing because it strongly affects product qual-
ity and acceptance (van Boekel, 1998). Several authors have 
reported beneficial effects of advanced Maillard reaction 
products (MRP) such as melanoidins, including antioxidative 
(Hiramoto et al., 2004; Echavarría et al., 2012), antimicro-
bial (Einarsson et al., 1983; Rufián-Henares and Morales, 
2007a, 2007b, 2008), antihypertensive (Rufián-Henares and 
Morales, 2007b), antimutagenic, and anticarcinogenic prop-
erties (Gu et al., 2010). Concerning antimicrobial activity, 
several reports highlighted the in vivo and in vitro effects of 
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monohydrate (262 mmol L−1) and butylamine (1.16 mol L−1) 
were dissolved in 1.28 mol L−1 phosphate buffer (pH 7.0). 
The sample solution (10 mL) was heated at 100℃ for 15 
min, and immediately cooled on ice. The heated sample solu-
tion was extracted three times with a double volume of ethyl 
acetate, and the ethyl acetate layer was evaporated to dry-
ness under reduced pressure. The residue was dissolved in 
10 mL of 20% methanol and filtered through a Sep-Pak Plus 
C18 cartridge (Waters Corporation, Milford, MA) (activated 
by 5 mL of ethanol and equilibrated using Milli-Q water) 
to remove brown components (melanoidins). The clear elu-
ate was evaporated again and freeze-dried under reduced 
pressure to collect the purified AR. In a previous study, Shi-
mamura et al. (2004) reported the 13C- and 1H-NMR data 
on this extracted product, and their signals were assigned to 
AR (1-(butylamino)-1,2-dehydro-1,4-dideoxy-3-hexulose). 
The concentration of AR was calculated with the extinction 
coefficient of AR (17.98 M−1 cm−1) at 320 nm (Trang et al., 
2008).
Brown, high-molecular-weight polymerized products 
are formed in the final stages of the Maillard reaction. These 
were named melanoidins by the French chemist Louis Ca-
mille Maillard (van Boekel, 1998). Because melanoidins 
showed antimicrobial activity against several pathogenic 
strains, as described above (Lanciotti et al., 1999, Rufián-
Henares and Morales, 2007a, 2007b; Rufián-Henares and 
Cueva, 2009), AR-derived MRP, which is a mixture of ad-
vanced MRP mainly containing melanoidins, was also used 
in this study. AR-derived MRP was prepared as follows: 
the purified AR solution was kept at room temperature for 
at least 3 weeks until the remaining amount of AR was less 
than 0.5%, as confirmed by the XTT assay or by estimating 
the absorbance at 320 nm (Trang et al., 2009).
Bacterial strains and culture conditions    The eight 
antibiotic-susceptible and -resistant pathogenic isolates, 4 
PA (P. aeruginosa), 1 MDRP (multi-drug-resistant P. aerugi-
nosa), 1 EC BL 21 (E. coli), 1 MSSA (methicillin-susceptible 
S. aureus) and 1 MRSA (methicillin-resistant S. aureus), 
were obtained from patients at Kochi Medical School Hos-
pital (Kochi, Japan). Two reference strains, S. aureus ATCC 
25923 (SA 25923) and E. coli ATCC 25922 (EC 25922), ob-
tained from the American Type Culture Collection were used 
as control strains to investigate the interaction between AR 
and antibiotics. All strains were grown on MHB agar plates 
supplemented with 1.4% agar and incubated at 37℃ for 24 h 
under aerobic conditions.
Disc diffusion susceptibility methods    The growth inhibi-
tion of pathogenic strains was assessed using the filter paper 
disc diffusion method on MHB agar plates, incubated at 37℃ 
under aerobic conditions (Nakhaei et al., 2008). Purified AR 
melanoidins against Bacillus stearothermophilus, a highly 
thermo-resistant microorganism involved in the degradation 
of food (Rufián-Henares and Morales, 2007b; Lanciott et al., 
1999), and pathogenic and spoilage bacteria frequently found 
in food, such as Escherichia coli (Rufián-Henares and Cue-
va, 2009), S. aureus (Einarsson et al., 1983; Rufián-Henares 
and Morales, 2008a; Rufián-Henares and Cueva, 2009), 
Salmonella enteritidis (Rufián-Henares and Morales, 2007a), 
and Bacillus subtilis (Rufián-Henares and Cueva, 2009).
The formation of aminoreductone (AR) (1-[Nε-(Nα-
acetyllysinyl)]-1,2- dehydro-4-deoxy-3-hexulose) in the 
initial stage of the Maillard reaction was first reported by 
Pischetsrieder et al. (1998) in a heated solution of lactose 
and Nα-acetyllysine (Pischetsrieder et al., 1998a). Shimam-
ura et al. (2011) reported the formation and presence of AR 
in milk using a combination of 2,4-dinitrophenylhydrazine 
(DNP) and Cu2+ (Shimamura et al., 2011). Because AR can 
be detected after only a short period of heating, it is an im-
portant indicator for estimating the extent of the Maillard 
reaction and heat treatment of food (Shimamura et al., 2004). 
Elucidation of the role and characteristics of AR are, there-
fore, of great interest to food scientists. To date, antioxidant 
activity (Pischetsrieder et al., 1998b), protective effects on 
photo-degradation of riboflavin (Trang et al., 2008), and 
antimicrobial activity against Helicobacter pylori, a Gram-
negative bacilli (Trang et al., 2009), have been reported for 
AR (1-(butylamino)-1,2-dehydro-1,4-dideoxy-3-hexulose), 
derived from the Maillard reaction of lactose and butylamine. 
In the search for alternatives to antibiotics, and to further de-
scribe the functional properties of AR, this study investigated 
the effects of AR against pathogenic bacteria, including P. 
aeruginosa (PA), multi-drug-resistant P. aeruginosa (MDRP), 
E. coli (EC), methicillin-susceptible S. aureus (MSSA) and 
methicillin-resistant S. aureus (MRSA).
Materials and Methods
Reagents    Mueller-Hinton broth (MHB) and commer-
cially available standard discs (ϕ = 6 mm) such as amikacin 
(AN; 30 μg disc−1), ciprofloxacin (CIP; 5 μg disc-1), imipe-
nem (IPM; 10 μg disc−1) and levofloxacin (LVX; 5 μg disc−1) 
were obtained from Becton, Dickinson and Company (Frank-
lin Lakes, New Jersey). Lactose monohydrate was purchased 
from Nacalai Tesque, Inc. (Kyoto, Japan). n-Butylamine and 
agar were obtained from Wako Pure Chemical Industries 
(Osaka, Japan). All other reagents were of the highest com-
mercial grade available. Milli-Q water or sterilized water 
was used in all procedures.
Preparation of AR and its degradation product    Purified 
AR was prepared according to previous reports (Pischetsrie-
der et al., 1998; Shimamura et al., 2004). Briefly, lactose 
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incubated under aerobic conditions with shaking (Bio shaker 
BR-40LF, Taitec Co., Ltd., Saitama, Japan) at 37℃ for 7 h. 
At 1, 3, 5 and 7 h after incubation, each 10 µL of the suspen-
sion was serially diluted 10-fold, inoculated onto the MHB 
agar plates and cultured for 24 h under aerobic conditions to 
determine cell viability. The ability of AR to kill pathogenic 
strains was evaluated by CFU counts in comparison with 
controls. All examinations were performed in triplicate.
Cluster analysis    Based on the results of the susceptibil-
ity tests with antibiotics and AR, all eight isolates were sub-
jected to cluster analysis (Townend, 2002).
Statistical analysis    All experimental data were analyzed 
using an analysis of variance (ANOVA) and significant dif-
ferences (P < 0.05) among means, from triplicate values, 
were determined using Duncan’s multiple range tests with 
SPSS (v.12.0 for windows, SPSS Inc, Chicago, IL).
Results
Inhibitory effects of AR against pathogenic bacteria 
The inhibitory effects of AR against eight pathogenic isolates 
and two reference strains were examined using the standard 
disc diffusion and the agar dilution methods. Table 1 shows 
the inhibition zone by AR (2.5 mg) for each isolate. Inhibi-
tion zones ranged from 9.5 mm (MDRP) to 28.3 mm (SA 
25923) in diameter, suggesting that all isolates were sensitive 
to AR at the tested concentration.
Previously, it was reported that the addition of Cu2+ could 
drastically reduce the concentration of AR because a labile 
reductone structure in AR could be readily oxidized (Shi-
mamura et al., 2004). In the presence of Cu2+, a considerable 
decrease in inhibition zone was observed for all isolates due 
to decreased concentrations of AR. The disc containing 5 μg 
of Cu2+ alone showed no inhibitory effect, indicating that AR 
per se possessed the potential ability to inhibit the growth of 
all pathogenic bacteria.
AR has a labile reductone structure and can easily change 
into intermediate and advanced MRP, including melanoidins, 
possessing antimicrobial activities (Einarsson et al., 1983; 
Rufián-Henares and Morales, 2008b; Rufián-Henares and 
Cueva, 2009). Next, AR-derived MRP, including melanoi-
dins, was utilized in the growth inhibition assay at a concen-
tration similar to each MIC value of AR. However, no inhibi-
tory effect was observed, showing that the AR-derived MRP, 
containing melanoidins, had no effect against any of the 
pathogenic strains under our experimental conditions (data 
not shown).
The inhibitory effects of AR against all isolates were 
confirmed by an agar dilution method at concentrations 
lower than 20 mmol L−1 (Table 1). MIC values range from 
13 mmol L−1 (MSSA) to 20 mmol L−1 (MDRP and PA4). The 
was diluted in Milli-Q water and dropped onto the disc. Ster-
ilized standard discs (ϕ = 6 mm) containing 2.5 mg of AR 
were placed on the MHB agar plates previously spread with 
0.1 mL of bacterial suspension (OD600 = 0.1) in MHB liquid 
medium. The plates were incubated at 37℃ for 24 h under 
aerobic conditions. The inhibition zones were measured and 
recorded in millimeters, and the average diameter of at least 
two repetitions was calculated. The entire diameter of the 
inhibition zone, including the diameter of the disc, was mea-
sured. Four standard commercially available antibiotic discs 
such as amikacin (AN: 30 μg disc−1), ciprofloxacin (CIP: 5 μg 
disc−1), imipenem (IPM: 10 μg disc−1) and levofloxacin (LVX; 
5 μg disc−1) were also used in this assay. An inhibition circle 
of more than 6 mm was defined as anti-bacterial activity.
Previously, Shimamura et al. (2004) observed that the ad-
dition of Cu2+, a strong oxidizing agent, drastically decreased 
AR content in the lactose-butylamine model solution. To 
confirm the contribution of AR to the inhibitory activities in 
this study, Cu2+ (5 µg) was added to the disc containing AR 
(2.5 mg) and changes in the inhibition zone were observed.
Determination of minimum inhibitory concentrations 
(MIC)    MIC of AR against pathogenic strains was deter-
mined using a previously described agar dilution method 
(Dore et al., 1999; Nakhaei et al., 2008). Purified AR was 
diluted in Milli-Q water. Aliquots (750 µL) of AR solution 
at given concentrations were added separately to each dish 
containing 14.25 mL of not-yet solidified MHB agar. The 
final concentrations of AR in the agar plates ranged from 
0 to 30 mmol L−1. Subsequently, each 10 µL of pathogenic 
strain suspension (OD600 = 0.1) was serially diluted 10-fold 
and inoculated onto the surface of the AR-supplemented agar 
plates, then incubated at 37℃ for 48 h under aerobic condi-
tions. Sterilized water was used as a control for all experi-
ments. The number of colony forming units (CFU) was de-
termined as a measure of bacterial viability (Takeuchi et al., 
2006). MIC was defined as the lowest AR concentration to 
inhibit 1 × 104−5 CFU mL−1 compared to controls. In addition, 
in this study, AR-derived MRP was also used and compared 
with AR. All tests were performed in at least triplicate.
Killing assay    To determine the bactericidal activity of 
AR against pathogenic bacteria, killing experiments were 
performed in the presence of 2, 5 or 10 × MIC of AR, accord-
ing to the previously described method (Dore et al., 1999). 
After 24 h of culture in MHB liquid medium, corresponding 
to the late exponential phase, the bacteria were harvested, 
washed with MHB liquid medium and then centrifuged at 
8,000 g for 1 min (KUBOTA 1120, Kubota Corp., Tokyo, Ja-
pan) to remove the supernatant. In 1.5-mL centrifuge tubes, 
0.4 mL of the bacterial suspension (109 CFU ml−1) in fresh 
MHB liquid medium with AR or without (controls) were 
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including MDRP, followed by E. coli at a concentration of 
2 × MIC (36 mmol L−1) of AR after 3 h of incubation. The 
biological behavior of the two S. aureus isolates did not dif-
fer significantly at any concentration of AR during the first 5 
h of incubation. However, the decrease in the concentration 
of MRSA appeared at 7 h, seemingly in a time-dependent 
manner. MSSA appears to be the most resistant strain to AR; 
its concentration decreased to 106 CFU mL−1 at 7 h with 10 × 
MIC of AR.
Verification of the antimicrobial activity of AR in combi-
nation with antibiotics    Drug interactions can be beneficial 
(synergistic or additive interaction) or deleterious (antago-
nistic or toxic outcome) (Adwan and Mhanna, 2008). The 
disc diffusion assay utilizing antibiotic and AR discs and the 
discs containing the mixtures demonstrated synergy, but no 
susceptibility of all isolates to widely used antibiotics (LVX, 
CIP, IPM and AN) compared with AR is listed in Table 1. In-
terestingly, all isolates, including MDRP, were susceptible to 
AR (2.5 mg). Cluster analysis completely separated the two S. 
aureus isolates from the other strains (data not shown).
Killing ability of AR against pathogenic bacteria    AR 
inhibited the bacterial growth of all isolates tested, except for 
MSSA. The in vitro activities of AR were further evaluated 
in killing assays with 2, 5 or 10 × MIC of AR to determine 
the minimum bactericidal concentrations (MBC) (Table 2). 
The bactericidal effects, a reduction of more than 104−5 CFU 
mL−1 of culturable cells, were mainly observed after 7 h of 
incubation for all isolates except MSSA (Figure 1). However, 
the effects were individual; the most potent killing activity 
was dose-dependently exhibited in P. aeruginosa isolates, 
Table 1.  Growth inhibition of pathogenic bacteria by aminoreductone.
No. Strain
*Inhibition zone (mm)
MIC of AR** 
(mmol L−1)AR 
(2.5 mg disc−1)
LVX 
(5 µg disc−1)
CIP 
(5 µg disc−1)
IPM 
(10 µg disc−1)
AN 
(30 µg disc−1)
1 MSSA 21.3 ± 1.4 33.0 ± 1.41 34.0 ± 1.4 53.0 ± 1.4 27.5 ± 0.7 14
2 MRSA 23.3 ± 0.7 16.0 ± 0.0 13.0 ± 0.7 n.d. 19.0 ± 0.0 13
3 PA1 11.5 ± 0.7 n.d. n.d. n.d. 9.0 ± 0.0 16
4 PA2 10.0 ± 1.4 n.d. n.d. n.d. 9.0 ± 0.0 18
5 PA3 11.0 ± 2.7 n.d. n.d. n.d. 16.0 ± 0.0 16
6 PA4 12.0 ± 0.0 n.d. n.d. n.d. 11.0 ± 0.7 20
7 MDRP 9.5 ± 0.7 n.d. n.d. n.d. n.d. 20
8 EC 10.3 ± 1.4 n.d. n.d. n.d. 8.0 ± 1.4 18
9 SA 25923 28.3 ± 0.4 31.0 ± 0.7 31.0 ± 0.0 32.8 ± 0,4 29.8 ± 0.4 14
10 EC 25922 20.9 ± 0.1 34.8 ± 0.5 32.3 ± 0.2 18.8 ± 0.7 29.0 ± 0.4 20
* Diameter of each disc was 6 mm and an inhibition circle > 6 mm was defined as anti-bacterial activity; Values are the mean of at least 
duplicate determinations; AR: aminoreductone; LVX: levofloxacin; CIP: ciprofloxacin; IPM: imipenem; AN: amikacin; n.d.: not deter-
mined; MSSA: methicillin-susceptible Staphylococcus aureus; MRSA: methicillin-resistant Staphylococcus aureus; SA 25923: Staphy-
lococcus aureus subsp. aureus ATCC® 25923; PA 1-4: Pseudomonas aeruginosa (4 individual isolates); MDRP: multi-drug-resistant 
Pseudomonas aeruginosa; EC: Escherichia coli; EC 25922: Escherichia coli ATCC® 25922.
** MIC was defined as the lowest AR concentration to inhibit 1 × 104−5 CFU mL−1 compared to controls.
Table 2.  Killing ability of aminoreductone against pathogenic bacteria after 7-h exposure to AR (aminoreductone).
No. Strains Resistance ability
Killing ability
MBC (mmol L−1) MBC/MIC
2× MIC 5 × MIC 10 × MIC
1 MSSA n.d. − − − n.d. n.d.
2 MRSA IPM − − + 130 10
3 PA1 LVX, CIP, IPM + + + 32 2
4 PA2 LVX, CIP, IPM + + + 36 2
5 PA3 LVX, CIP, IPM + + + 32 2
6 PA4 LVX, CIP, IPM + + + 40 2
7 MDRP LVX, CIP, IPM, AN + + + 40 2
8 EC LVX, CIP, IPM + + + 36 2
(+) Bactericidal and (−) no bactericidal effects.
n.d., not determined; LVX, levofloxacin; CIP, ciprofloxacin; IPM, imipenem; AN, amikacin; MIC, minimum inhibitory concentration; 
MBC, minimum bactericidal concentration
836
Antimicrobial Activity of Aminoreductone
1 kind of antibiotic (IPM). AR is a product formed in food 
during heat treatment and is not a medicine, which may pos-
sess side effects. Thus, similar to other active products found 
in foods or herbs, a higher amount of AR is needed to exert 
antimicrobial activity compared with antibiotics. The amount 
of AR obtained depends on the food source. For example, 25 
mg of AR can be gained from 200 mL of UHT milk (Trang et 
al., 2009). These amounts are achievable for daily consump-
tion. Furthermore, we confirmed that AR exhibited growth 
inhibition, even against antibiotic-resistant strains. These 
results revealed that AR showed advanced growth inhibition 
antagonistic effects, even in drug-resistant isolates, indicat-
ing that AR does not interfere with the activity of antibiotics 
(Figure 2).
Discussion
Pathogenic bacteria that have developed resistance to 
multiple antibiotics, particularly MRSA and MDRP, are of 
grave concern to immunocompromised patients, as they 
are responsible for nosocomial infections. In this study, PA 
and EC BL 21 showed resistance to three kinds of antibiot-
ics (LVX, CIP, IPM) and MRSA demonstrated resistance to 
MSSA
MRSA
PA1
PA3 
MDRP 
EC 
Fig. 1.  Bactericidal effects of AR (aminoreductone) using multiples of MIC (minimum inhibitory concentration).
◆, without AR (control); ■, 2 × MIC; ▲, 5 × MIC; ●, 10 × MIC;
MSSA: methicillin-susceptible Staphylococcus aureus
MRSA: methicillin-resistant Staphylococcus aureus
PA: Pseudomonas aeruginosa (individual isolates)
MDRP: multi-drug-resistant Pseudomonas aeruginosa
EC: Escherichia coli
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(Darville, 1999) or AN (Carrier et al., 1997) are widely used 
alone or in combination with other antimicrobial agents for 
the treatment of several serious infections caused by Gram-
negative and -positive bacteria. Combined antibiotic therapy 
has been shown to delay the emergence of bacterial resis-
tance and may also produce desirable synergistic effects in 
clinical settings (Adwan and Mhanna, 2008). The experi-
ments combining antibiotics and AR were carried out by 
the standard disc diffusion method, which is widely used to 
study the bioactivity of chemical compounds (Rufián-Henares 
and Morales, 2008a). The ability of compounds to diffuse 
through the nutrient agar medium is a major limitation in 
the evaluation of the antimicrobial effects of the compounds 
concerned. The contact area of the two inhibition zones of 
antibiotic and AR expressed the effects of both AR and anti-
biotic against bacteria. Synergy has generally been defined as 
effects at the tested concentration compared to antibiotics. 
Thus, AR could be used either as an alternative antimicrobial 
agent or as an adjuvant therapy for infectious diseases.
AN (amikacin), an aminoglycoside, inhibits protein syn-
thesis by “irreversibly” binding to the 30S ribosomal subunit, 
thus preventing the formation of an initiation complex with 
messenger RNA (Carrier et al., 1997). Of the four antibiot-
ics used, AN showed the highest inhibitory effect, similar 
to the effect of AR (except for MDRP), suggesting that AN 
could be used as a reliable reference during investigation of 
AR antimicrobial activity. AN has been generally recognized 
to have some serious adverse effects, such as nephrotoxicity 
and permanent vestibular and/or auditory ototoxicity (Carrier 
et al., 1997); hence, the use of AR could be an appropriate 
alternative to AN. The fluoroquinolone antibacterial agents 
LVX and CIP (Mori et al., 2000), β-lactam antibiotics (IPM) 
Fig. 2.  Combinational effect of AR (aminoreductone) and antibiotics.
The inhibition zones of four antibiotic discs (CIP (A), LVX (B), AN (C) or IPM (D) in combination with 2.5 mg of AR (top row) and the 
mixtures of each antibiotic + AR (bottom row) in Escherichia coli ATCC® 25922. Top row: Arrows (B and C) indicate the obscure border 
areas due to fusion at the contact point with the inhibition zones induced by AR and antibiotics, suggesting that a synergistic effect inhibits 
growth. Bottom row: The size of inhibition zones was not reduced using mixtures, indicating no antibiotic antagonism and no obstacle to 
diffusion. AR does not interfere with the activity of antibiotics.
Zoom-in figures (B and C). Bacterial inhibition (arrow) beyond the inhibition circles (white line) was observed as a synergistic effect of anti-
biotics and AR.
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function of AR might be due to the thickness of the bacterial 
cell wall, as well as the outer membrane-related components. 
In other words, AR efficacy might depend on the constitutive 
elements of bacterial structures. To elucidate this issue, fur-
ther investigations using improved AR or AR-derived com-
pounds, and identification of the biochemical characteristics 
of AR, including its molecular structure, are required.
To date, the majority of attention has been paid to high-
molecular-weight MRP, such as melanoidins, on the topic 
of antimicrobial activity. It was reported that the growth 
inhibitory activity and bactericidal activity against E. coli 
increased depending on the molecular weight of MRP (< 3 
kDa, 3-10 kDa and > 10 kDa) (Rufián-Henares and Morales, 
2008b). Einarsson et al. (1983) showed that the growth in-
hibitory activity of MRP with molecular weight > 1 kDa was 
higher than that with < 1 kDa molecular weight. However, 
our study demonstrated for the first time that low-molecular 
weight MRP such as AR (217 Da) can exhibit bacteriostatic 
and bactericidal properties. It is noteworthy that AR pos-
sesses antimicrobial activity against pathogenic bacteria. AR 
from lactose and butylamine showed high reducing activity 
(Shimamura et al., 2004). Lanciotti et al. (1999) suggested 
that the inhibitory effect against B. stearothermophilus was 
influenced by the reduction of the redox potential in the 
growth medium, as a consequence of the addition of MRP 
with high reducing properties. Therefore, the effect of AR 
against pathogenic bacteria might be partially caused by its 
reducing ability.
The killing assay has been suggested to be one of the 
most reliable methods for determining the susceptibility of 
microorganisms to antimicrobial compounds and antibiotics 
(Dore et al., 1999). The killing effect of AR was not associ-
ated with drug susceptibility, but appears to depend on bacte-
rial morphology, such as in Gram-positive cocci and Gram-
negative rods. According to Oussou et al. (2008), the ratio 
of MBCs to MICs (MBC:MIC < 4) indicated that the effect 
of AR was bactericidal for all Gram-negative strains tested, 
while it was bacteriostatic for MRSA (MBC:MIC = 10) 
(Oussou et al., 2008). In our study, Gram-positive S. aureus 
isolates were more resistant to AR than the other Gram-neg-
ative isolates, confirming the results of the cluster analysis 
(Table 2 and Figure 1). Furthermore, MRSA showed higher 
sensitivity than MSSA at 10 × MIC, implying that a higher 
concentration than 10 × MIC of AR may be required to kill 
MSSA. Such a difference in the effectiveness of AR between 
Gram-positive and -negative bacteria is an important clue in 
discovering the molecular function of AR in microorganisms. 
In addition, the antibacterial functions of AR probably differ 
from those of the antibiotics used in the present study.
Here, we report for the first time that AR inhibits the 
the increased inhibitory effect of antimicrobials in combina-
tion compared with each used alone. As showed in Fig. 2, an 
obscure border area was observed at the contact point of the 
inhibition zones induced by AR and antibiotics (Fig. 2). In 
the zoom-in figures (B and C), the bacterial inhibition (arrow) 
beyond the inhibition circles (white line) was observed as the 
synergistic effect of antibiotics (LVX, AN) and AR. Further-
more, in drug-resistant isolates, several colonies appeared 
within the inhibition zone of the discs containing LVX, CIP 
or IPM. This phenomenon indicated the tested antibiotics are 
not intended to inhibit those organisms. These drug-resistant 
strains will reduce the effectiveness of an antibiotic. How-
ever, no bacteria were observed in the inhibition zones when 
AR or the mixtures were used in combination, implying that 
the combination of antibiotics and AR is useful and may pre-
vent the occurrence of resistant strains. On the other hand, in 
the disc diffusion method with AR and antibiotics, and the 
combination of these agents, no bacterial growth (colony) 
was observed in the area where the two agents overlapped 
(the inhibition zones, as well as the contact area of the two 
inhibition zones of AR and antibiotics) (Figure 2). These 
results indicated that no analogical effect was observed with 
combinations of antibiotics and AR. In other word, AR does 
not repress the inhibitory effect of antibiotics. In fact, the 
synergistic effect observed suggested that AR might enhance 
the inhibition effect of tested antibiotics in the treatment of 
pathogenic bacteria. These results lead us to consider combi-
natorial approaches based on foods containing AR for daily 
health and medical application.
The exact mechanism by which Maillard reaction prod-
ucts affect bacterial growth is not yet understood. However, 
it has been suggested that high-molecular-weight compounds 
with anionic charge, like melanoidins, could develop anti-
microbial activity by binding essential metals, such as iron, 
copper, and zinc, which are key elements in cell metabolism 
and are essential for the growth and survival of pathogenic 
bacteria (Rufián-Henares and Morales, 2008b; Rufián-
Henares and Cueva, 2009). The antimicrobial activity of the 
Maillard reaction compounds involved interference with the 
uptake of serine, glucose, and oxygen, thereby inhibiting the 
sugar catabolizing enzymes of microorganisms by causing 
irreversible changes in both the inner and outer cell mem-
branes, followed by inhibition of nutrient transport (Lanciotti 
et al., 1999). It is thought that the functional activity of mela-
noidins against Gram-negative bacteria involves membrane 
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